Search

everythinglearnresearchcommunity

for

Search:↓

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Cyclosporin A is highly toxic to rats, causing severe health issues and death.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Clofazimine may be effective for treating ashy dermatosis.

Nanotechnology can improve cervical cancer treatment by targeting drugs better and reducing side effects.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Tofacitinib taken by mouth helps treat hair loss in children.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

[6]-Gingerdiol 3-monoacetate shows promise for treating T. whipplei infections.

FK506 may stimulate hair growth when applied to the skin.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Baricitinib is a promising treatment for alopecia areata.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Immunosuppression therapy with methylprednisolone effectively treats childhood alopecia areata.

Tofacitinib helped a man with alopecia totalis regrow all his hair.

New treatments for chronic central serous chorioretinopathy show promise in preventing permanent vision loss.

A rabbit with sebaceous adenitis was effectively treated with ciclosporin and medium-chain triglycerides.

Follicular dystrophy in immunocompromised patients may be linked to medication or viral factors and can improve with treatment changes.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.

New medications could improve treatment for severe alopecia areata in Australia.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.